Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme

FEBS Letters

Volumn 481, Issue 2, 2000, Pages 113-116

  Toyoda, Tetsuya ^a   Imamura, Yoshihiro ^a   Takaku, Hiroshi ^b   Kashiwagi, Takahito ^a   Hara, Koyu ^a   Iwahashi, Jun ^a   Ohtsu, Yasushi ^a   Tsumura, Naoki ^a   Kato, Hirohisa ^a   Hamada, Nobuyuki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Antisense oligonucleotide; Influenza virus; PB2; RNA cleaving DNA enzyme

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA; ENZYME;

ARTICLE; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA CLEAVAGE; START CODON; VIRUS INHIBITION;

ANIMAL; BASE SEQUENCE; BINDING SITES; CATALYSIS; CELL LINE; CODON, INITIATOR; DNA, SINGLE-STRANDED; DOGS; HYDROGEN-ION CONCENTRATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; ORTHOMYXOVIRIDAE; RNA, MESSENGER; RNA, VIRAL; SALTS; SUBSTRATE SPECIFICITY; TRANSFECTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0034666079     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01974-8     Document Type: Article

References (21)

1. Akhtar S., Agrawal S. Trends Pharmacol. Sci. 18:1997;12-18.
2. Agrawal S., Zhao Q. Curr. Opin. Chem. Biol. 2:1998;519-528.
3. Levin A.A. Biochem. Biophys. Acta. 1489:1999;69-84.
4. Santoro S.W., Joyce G.F. Proc. Natl. Acad. Sci. USA. 94:1997;4262-4266.
5. Santoro S.W., Joyce G.F. Biochemistry. 37:1998;13330-13342.
6. Dash B.C., Harikrishnan T.A., Goila R., Shali S., Unwalla H., Husain S., Banerjea A.C. FEBS Lett. 431:1998;395-399.
7. Goila R., Banerjea A.C. FEBS Lett. 436:1998;233-238.
8. Zhang X., Xu Y., Ling H., Hattri T. FEBS Lett. 458:1999;151-156.
9. Hatta T., Nakagawa Y., Takai K., Nakada S., Yokota T., Takaku H. Nucleic Acids Symp. Ser. 34:1995;129-130.
10. Hatta T., Nakagawa Y., Takai K., Nakada S., Yokota T., Takaku H. Biochem. Biophys. Res. Commun. 223:1996;341-346.
11. Hatta T., Takai K., Nakada S., Yokota T., Takaku H. Biochem. Biophys. Res. Commun. 232:1997;545-549.
12. Abe T., Suzuki S., Hatta T., Takai K., Yokota T., Takaku H. Antivir. Chem. Chemother. 9:1998;253-262.
13. Abe T., Hatta T., Takai K., Nakashima H., Yokota T., Takaku H. Nucleosides Nucleotides. 17:1998;471-478.
14. Abe T., Mizuta T., Suzuki S., Hatta T., Takai K., Yokota T., Takaku H. Nucleosides Nucleotides. 18:1999;1685-1688.
15. Mizuta T., Fujiwara M., Hatta T., Abe T., Miyano-Kurosaki N., Shigeta S., Yokota T., Takaku H. Nat. Biotechnol. 17:1999;583-587.
16. Young, J.F., Desselberger, U., Graves, U., Palese, P., Shatzman, A. and Rosenburg, M. (1983) in: The Origin of Pandemic Influenza Viruses (Laver, W.G., Ed.), pp. 129-138, Elsevier, New York.
17. Yasuda J., Toyoda T., Nakayama M., Ishihama A. Arch. Virol. 133:1993;283-294.
18. Breaker R.R., Joyce G.F. Chem. Biol. 2:1995;660-665.
19. Honda A., Mukaigawa J., Yokoiyama A., Kato A., Ueda S., Nagata K., Krystal M., Nayak D.P., Ishihama A. Biochemistry. 107:1990;624-628.
20. Lamb, R.A. and Krug, R.M. (1996) in: Virology (Fields, B.N. et al., Eds.), 3rd edn., pp. 1353-1395, Lippincott-Raven, Philadelphia.
21. Toyoda T., Masunaga K., Ohtsu Y., Hara K., Hamada N., Koga M., Kashiwagi T., Iwahashi J. Rec. Res. Dev. Virol. 1:1999;839-847.